Limitations
COVID -19 is new. Trials are being registered and updated almost weekly, so it is impossible to give the most current status of therapeutic trials world-wide. We selected the most trialled drugs as at the time of initiation of review.
Some trials were conducted in languages other than English and were not reviewed.
The number of drugs under trials are too many and practically not feasible to review all in this context.